3.25
Abvc Biopharma Inc Aktie (ABVC) Neueste Nachrichten
Is ABVC BioPharma Inc. a good long term investmentConsistent double returns - jammulinksnews.com
What drives ABVC BioPharma Inc. stock priceSuperior profit margins - jammulinksnews.com
Sixteen new option listings on July 23rd - TipRanks
ABVC BioPharma Inc Inc. (ABVC) Price Performance: A Comparative Analysis with Competitors - investchronicle.com
What analysts say about ABVC BioPharma Inc. stockStrong return on assets - jammulinksnews.com
Is ABVC BioPharma Inc. stock a growth or value playAlpha Stock Ideas - Newser
ABVC BioPharma Inc. Stock Analysis and ForecastFree Advanced Stock Screener Access - jammulinksnews.com
What makes ABVC BioPharma Inc. stock attractive to long term investorsValue Pick Scanner - Newser
ABVC BioPharma Records $100,000 Licensing Milestone From ForSeeCon, Strengthening Eye Health Program - Yahoo Finance
What makes ABVC BioPharma Inc. stock price move sharplySteady Profit Stock Forecasts - Newser
Why ABVC BioPharma Inc. stock attracts strong analyst attentionDaily Gain Forecast - Newser
How ABVC BioPharma Inc. stock performs during market volatilityFree Exclusive Access to Stock Gurus - Newser
ABVC BioPharma Soars 16%—Is This the Breakout Biotech Investors Have Been Waiting For? - AInvest
ABVC BioPharma Receives $150K Milestone From AiBtl, Bringing Total Licensing Revenue to $846K Across Strategic Partnerships - Yahoo Finance
ABVC BioPharma CEO Dr. Uttam Patil Recognized Among Elite Indian-Origin CEOs Making Global Impact in Science and Technology - StreetInsider
ABVC BioPharma Converts Strategic Note Into Equity in AiBtl BioPharma; Commits to Up to $20 Million in Total Investment - Yahoo Finance
ABVC BioPharma's Affiliate OncoX Acquires Lycopenoid Platform to Strengthen Oncology Portfolio - citybuzz -
ABVC BioPharma Expands Oncology Portfolio as Affiliate OncoX Acquires Patented Lycopenoid Platform Valued at $4.06 Million - The Globe and Mail
ABVC BioPharma Shareholders Approve Key Proposals - TipRanks
ABVC BioPharma Announces Board Approval of Share Dividend Showing Confidence in Subsidiary Growth and Long-Term Shareholder Value - Yahoo Finance
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):